High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
Open Access
- 16 December 2010
- journal article
- Published by Springer Science and Business Media LLC in Parasites & Vectors
- Vol. 3 (1), 120
- https://doi.org/10.1186/1756-3305-3-120
Abstract
Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent children from becoming infected. This level of coverage has been a challenge in urban settings. Assessing the coverage in a rapidly growing urban/non-rural setting with inadequate population data is also problematic. In Sierra Leone, a 5-day preventative chemotherapy campaign was carried out in the Western Area including the capital: Freetown. An intensive, social mobilization strategy combined traditional and modern communication channels. To aid dissemination of appropriate information Frequently Asked Questions were developed and widely circulated. The population of the Western Area has grown faster than projected by the 2004 National Census due to the post-war settlement of internally displaced persons. As a reliable denominator was not available, independent monitoring was adapted and performed "in process" to aid program performance and "end process" to assess final coverage. In 5 days 1,104,407 eligible persons were treated. Using the projected population from the 2004 census this figure represented coverage of 116% in the Urban Western Area and 129% in the Rural Western Area. Independent monitors interviewed a total of 9,253 persons during the 2 End Process days representing 1% of the projected population. Of these, 85.8% recalled taking both ivermectin and albendazole (Urban: 85.2%, Rural: 87.1%). No serious adverse drug reactions were reported. The paper presents the key elements of success of the social mobilization and implementation strategy and describes the independent monitoring used to estimate final coverage in this urban/non-rural setting where the current population size is uncertain. This implementation strategy and Independent Monitoring tool could be useful in similar, rapidly growing cities implementing lymphatic filariasis elimination programs.Keywords
This publication has 8 references indexed in Scilit:
- Community's Knowledge and Perceptions about Filarial Elephantiasis and Hydrocele in Coastal Orissa, IndiaAsia Pacific Journal of Public Health, 2007
- Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri LankaFilaria Journal, 2007
- A campaign of 'communication for behavioural impact' to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coveragePathogens and Global Health, 2006
- Participation in three consecutive mass drug administrations in Leogane, HaitiTropical Medicine & International Health, 2006
- Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasisPathogens and Global Health, 2005
- Treatment strategies underpinning the global programme to eliminate lymphatic filariasisExpert Opinion on Pharmacotherapy, 2005
- Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, IndiaTropical Medicine & International Health, 2004
- A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single‐dose DEC mass treatment and some related operational aspectsTropical Medicine & International Health, 2000